Literature DB >> 36044118

Mechanism Study on Chinese Medicine in Treatment of Nodular Goiter.

Chang-Lin Wang1,2,3, Ming-Zhou Gao1,2,3, Xiang-Ju Gao1,2,3, Xiang-Yu Mu1,2,3, Jie-Qiong Wang2,3,4,5, Dong-Mei Gao1,2,3, Ming-Qi Qiao6,7,8.   

Abstract

Nodular goiter has become increasingly prevalent in recent years. Clinically, there has been a burgeoning interest in nodular goiter due to the risk of progression to thyroid cancer. This review aims to provide a comprehensive summary of the mechanisms underlying the therapeutic effect of Chinese medicine (CM) in nodular goiter. Articles were systematically retrieved from databases, including PubMed, Web of Science and China National Knowledge Infrastructure. New evidence showed that CM exhibited multi-pathway and multi-target characteristics in the treatment of nodular goiter, involving hypothalamus-pituitary-thyroid axis, oxidative stress, blood rheology, cell proliferation, apoptosis, and autophagy, especially inhibition of cell proliferation and promotion of cell apoptosis, involving multiple signal pathways and a variety of cytokines. This review provides a scientific basis for the therapeutic use of CM against nodular goiter. Nonetheless, future studies are warranted to identify more regulatory genes and pathways to provide new approaches for the treatment of nodular goiter.
© 2022. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chinese medicine; mechanism; nodular goiter; pharmacology; review

Year:  2022        PMID: 36044118     DOI: 10.1007/s11655-022-3724-3

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   2.626


  49 in total

Review 1.  Thyroid Hormone Suppression Therapy.

Authors:  Bernadette Biondi; David S Cooper
Journal:  Endocrinol Metab Clin North Am       Date:  2018-12-04       Impact factor: 4.741

Review 2.  Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis.

Authors:  Sae Rom Chung; Chong Hyun Suh; Jung Hwan Baek; Hye Sun Park; Young Jun Choi; Jeong Hyun Lee
Journal:  Int J Hyperthermia       Date:  2017-06-26       Impact factor: 3.914

3.  Toxic nodular goiter and thyroid cancer: Is hyperthyroidism protective against thyroid cancer?

Authors:  Abbas Ali Tam; Didem Ozdemir; Afra Alkan; Omer Yazicioglu; Nilufer Yildirim; Aylin Kilicyazgan; Reyhan Ersoy; Bekir Cakir
Journal:  Surgery       Date:  2019-05-16       Impact factor: 3.982

Review 4.  Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.

Authors:  M Knobel
Journal:  J Endocrinol Invest       Date:  2015-09-21       Impact factor: 4.256

5.  Thyroid Nodules.

Authors:  James Wu
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-06-01       Impact factor: 6.223

6.  Risk factors for postoperative bleeding after thyroid surgery.

Authors:  R Promberger; J Ott; F Kober; C Koppitsch; R Seemann; M Freissmuth; M Hermann
Journal:  Br J Surg       Date:  2012-01-09       Impact factor: 6.939

Review 7.  Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma.

Authors:  Ilgin Yildirim Simsir; Sevki Cetinkalp; Taylan Kabalak
Journal:  Med Princ Pract       Date:  2019-09-23       Impact factor: 1.927

8.  Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.

Authors:  Hyun Kyung Lim; Jung Hwan Baek; Jeong Hyun Lee; Won Bae Kim; Tae Yong Kim; Young Kee Shong; Suck Joon Hong
Journal:  Eur Radiol       Date:  2014-09-09       Impact factor: 5.315

Review 9.  Thyroid cancer management: from a suspicious nodule to targeted therapy.

Authors:  Francesco Perri; Antonio Giordano; Salvatore Pisconti; Franco Ionna; Maria G Chiofalo; Francesco Longo; Davide Leopardo; Giuseppina Della Vittoria Scarpati; Luciano Pezzullo
Journal:  Anticancer Drugs       Date:  2018-07       Impact factor: 2.248

Review 10.  Overview of Thyroid Surgery Complications.

Authors:  Juraj Lukinović; Mario Bilić
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.